SEOUL, Dec. 10 (Korea Bizwire) — At least 35 cases of adverse reactions, including several categorized as “serious,” have been reported in South Korea within a month of the launch of Mounjaro, Eli Lilly’s new obesity and diabetes treatment, according to data released Wednesday. The figures were submitted to Rep. Seo Mi-hwa of the Democratic Party [...]
SEOUL, Nov. 5 (Korea Bizwire) — As the South Korean government tightens oversight of new weight-loss drugs such as Wegovy and Mounjaro to curb misuse, some users are sidestepping domestic restrictions by traveling to Japan for easier access. Despite recent price stabilization in the domestic market, a growing number of South Koreans are turning to Japanese [...]
SEOUL, Oct. 28 (Korea Bizwire) — South Korea plans to tighten oversight of blockbuster obesity treatments such as Wegovy and Mounjaro, responding to a surge in prescriptions for cosmetic weight loss among people without medical need, the government said Monday. The Ministry of Health and Welfare said it will work with the country’s drug regulator to [...]